DOTA-BP1
DOTA-BP1 is a DOTA-modified BP1 (BCMA-targeting peptide) . DOTA-BP1 can be radiolabeled with [68Ga]Ga to produce a BCMA-targeting PET tracer. DOTA-BP1 can be used in the research of detecting BCMA in multiple myeloma[1].
Product Specifications
UNSPSC
12352209
Target
Radionuclide-Drug Conjugates (RDCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Field of Research
Cancer
Smiles
O=C([C@@H](NC(CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)=O)CCC(O)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CS)=O)CC2=CC=CC=C2)=O)CC(O)=O)=O)CC3=CC=C(O)C=C3)=O)CC4=CC=CC=C4)=O)CS)=O)CC5=CC=C(O)C=C5)=O)CCC(O)=O
Molecular Formula
C72H93N13O25S2
Molecular Weight
1604.71
References & Citations
[1]Song L, et al. Development of a Novel Peptide-Based PET Tracer [68Ga]Ga-DOTA-BP1 for BCMA Detection in Multiple Myeloma. J Med Chem. 2024 Sep 12;67 (17) :15118-15130.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742216-100 1x 100 µL
CD50 / ICAM3 (CG106), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741621-500 1x 500 µL
Endoglin / CD105 (ENG/1621), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682651-500 1x 500 µL
Interleukin 10 (IL10) (Immunoregulation Marker) (IL10/2651R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040901-100 1x 100 µL
Adenosine Monophosphate Deaminase 3 (AMPD3) (AMPD3/901), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details